Aldeyra Therapeutics-Insiders Scoop Up Shares of These 5 Stocks for the Second Quarter

Core Insights - Insider purchases have decreased in number and size as the second quarter begins, but notable purchases were still made by influential investors like Mario Gabelli and TotalEnergies [1] - Insider buying is often viewed as a positive signal for potential investors, especially during uncertain market conditions [1] Company Summaries - GAMCO Natural Resources, Gold & Income Trust - Total shares purchased: 870,000 - Price per share: $10.00 - Total cost:$ 8.7 million - Shares have increased over 8% since the purchase, with a yield of about 7.4% and monthly distributions [3] - Boundless Bio Inc. - Total shares purchased: 512,500 - Price per share: $16.00 - Total cost:$ 8.2 million - Shares have declined since the IPO, currently trading around $13, with five of seven analysts recommending a buy [4] - **Five Star Bancorp** - Total shares purchased: less than 252,900 - Price per share:$ 21.75 - Total cost: approximately $5.5 million - The stock is down about 16% year-to-date, but analysts suggest a 30% upside based on a$ 28.67 consensus price target [5] - Clearway Energy Inc. - Total shares purchased: almost 197,000 - Price per share: $22.54 to$ 23.08 - Total cost: around $4.5 million - Despite a recent 3% increase, shares are down over 13% year-to-date, but 27% higher than the 52-week low [7] - **Aldeyra Therapeutics Inc.** - Total shares purchased: almost 504,300 - Price per share:$ 3.24 to $4.21 - Total cost: over$ 1.9 million - The stock surged about 43% following FDA approval plans, with a consensus price target of $9.25 suggesting potential for nearly double the current price [8]